These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Topical tacrolimus is more effective for treatment of vitiligo in patients of skin of color. Silverberg JI; Silverberg NB J Drugs Dermatol; 2011 May; 10(5):507-10. PubMed ID: 21533297 [TBL] [Abstract][Full Text] [Related]
43. Tetrahydrocurcuminoid cream plus targeted narrowband UVB phototherapy for vitiligo: a preliminary randomized controlled study. Asawanonda P; Klahan SO Photomed Laser Surg; 2010 Oct; 28(5):679-84. PubMed ID: 20961233 [TBL] [Abstract][Full Text] [Related]
44. Topical pimecrolimus: a new horizon for vitiligo treatment? Sendur N; Karaman G; Saniç N; Savk E J Dermatolog Treat; 2006; 17(6):338-42. PubMed ID: 17853306 [TBL] [Abstract][Full Text] [Related]
45. Pimecrolimus cream in the long-term management of atopic dermatitis in adults: a six-month study. Meurer M; Fölster-Holst R; Wozel G; Weidinger G; Jünger M; Bräutigam M; Dermatology; 2002; 205(3):271-7. PubMed ID: 12399676 [TBL] [Abstract][Full Text] [Related]
46. Effect of topical calcipotriol, betamethasone dipropionate and their combination in the treatment of localized vitiligo. Kumaran MS; Kaur I; Kumar B J Eur Acad Dermatol Venereol; 2006 Mar; 20(3):269-73. PubMed ID: 16503885 [TBL] [Abstract][Full Text] [Related]
47. Rosaceiform dermatitis as a complication of treatment of facial seborrheic dermatitis with 1% pimecrolimus cream. Gorman CR; White SW Arch Dermatol; 2005 Sep; 141(9):1168. PubMed ID: 16172323 [No Abstract] [Full Text] [Related]
48. Vitix--a new treatment for vitiligo? Schallreuter KU; Rokos H Int J Dermatol; 2005 Nov; 44(11):969-70. PubMed ID: 16336538 [No Abstract] [Full Text] [Related]
49. Results of a randomized, double-blind, vehicle-controlled efficacy trial of pimecrolimus cream 1% for the treatment of moderate to severe facial seborrheic dermatitis. Warshaw EM; Wohlhuter RJ; Liu A; Zeller SA; Wenner RA; Bowers S; Schultz JC; Katz HI; McCormick CL; Parneix-Spake A J Am Acad Dermatol; 2007 Aug; 57(2):257-64. PubMed ID: 17188780 [TBL] [Abstract][Full Text] [Related]
50. Does topical tacrolimus ointment enhance the efficacy of narrowband ultraviolet B therapy in vitiligo? A left-right comparison study. Majid I Photodermatol Photoimmunol Photomed; 2010 Oct; 26(5):230-4. PubMed ID: 20831696 [TBL] [Abstract][Full Text] [Related]
51. In vivo vitiligo induction and therapy model: double-blind, randomized clinical trial. van Geel N; Speeckaert R; Mollet I; De Schepper S; De Wolf J; Tjin EP; Luiten RM; Lambert J; Brochez L Pigment Cell Melanoma Res; 2012 Jan; 25(1):57-65. PubMed ID: 21982055 [TBL] [Abstract][Full Text] [Related]
52. Pimecrolimus 1% cream for cutaneous lupus erythematosus. Kreuter A; Gambichler T; Breuckmann F; Pawlak FM; Stücker M; Bader A; Altmeyer P; Freitag M J Am Acad Dermatol; 2004 Sep; 51(3):407-10. PubMed ID: 15337984 [TBL] [Abstract][Full Text] [Related]
53. An open-label pilot study to evaluate the safety and efficacy of topically applied pimecrolimus cream for the treatment of steroid-induced rosacea-like eruption. Chu CY J Eur Acad Dermatol Venereol; 2007 Apr; 21(4):484-90. PubMed ID: 17373975 [TBL] [Abstract][Full Text] [Related]
54. Influence of pimecrolimus cream 1% on different morphological signs of eczema in infants with atopic dermatitis. Breuer K; Braeutigam M; Kapp A; Werfel T Dermatology; 2004; 209(4):314-20. PubMed ID: 15539895 [TBL] [Abstract][Full Text] [Related]
55. Efficacy of topical tacrolimus in the treatment of various cutaneous manifestations of lupus erythematosus. von Pelchrzim R; Schmook T; Friedrich M; Worm M Int J Dermatol; 2006 Jan; 45(1):84-5. PubMed ID: 16426386 [No Abstract] [Full Text] [Related]
56. Topical pimecrolimus in the treatment of vitiligo. Boone B; Ongenae K; Van Geel N; Vernijns S; De Keyser S; Naeyaert JM Eur J Dermatol; 2007; 17(1):55-61. PubMed ID: 17324829 [TBL] [Abstract][Full Text] [Related]
57. The treatment of facial atopic dermatitis in children who are intolerant of, or dependent on, topical corticosteroids: a randomized, controlled clinical trial. Hoeger PH; Lee KH; Jautova J; Wohlrab J; Guettner A; Mizutani G; Hultsch T Br J Dermatol; 2009 Feb; 160(2):415-22. PubMed ID: 19067708 [TBL] [Abstract][Full Text] [Related]
58. The use of 1% pimecrolimus cream for the treatment of steroid-induced rosacea. Chu CY Br J Dermatol; 2005 Feb; 152(2):396-9. PubMed ID: 15727676 [No Abstract] [Full Text] [Related]
59. Safety and efficacy of nonsteroid pimecrolimus cream 1% in the treatment of atopic dermatitis in infants. Ho VC; Gupta A; Kaufmann R; Todd G; Vanaclocha F; Takaoka R; Fölster-Holst R; Potter P; Marshall K; Thurston M; Bush C; Cherill R J Pediatr; 2003 Feb; 142(2):155-62. PubMed ID: 12584537 [TBL] [Abstract][Full Text] [Related]
60. Topical tacrolimus and the 308-nm excimer laser: a synergistic combination for the treatment of vitiligo. Passeron T; Ostovari N; Zakaria W; Fontas E; Larrouy JC; Lacour JP; Ortonne JP Arch Dermatol; 2004 Sep; 140(9):1065-9. PubMed ID: 15381545 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]